BioCryst Pharmaceuticals Inc. (BCRX)
NASDAQ · Healthcare
BioCryst Pharmaceuticals Inc. Net Income 2009–2025
BioCryst Pharmaceuticals Inc. annual/quarterly net income history and growth rate from 2009 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- BioCryst Pharmaceuticals Inc. net income for the quarter ending March 31, 2026 was -721.8 M, a 2255762.50% decrease year-over-year.
- BioCryst Pharmaceuticals Inc. net income for the twelve months ending March 31, 2026 was -703.8 M, a 616.44% increase year-over-year.
- BioCryst Pharmaceuticals Inc. annual net income for 2025 was 263.9 M, a 396.87% decrease from 2024.
- BioCryst Pharmaceuticals Inc. annual net income for 2024 was -88.9 M, a 60.77% decrease from 2023.
- BioCryst Pharmaceuticals Inc. annual net income for 2023 was -226.5 M, a 8.33% decrease from 2022.
- BioCryst Pharmaceuticals Inc. annual net income for 2022 was -247.1 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
BioCryst Pharmaceuticals Inc. Net Income — FAQ
BioCryst Pharmaceuticals Inc. (BCRX) net income over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
What is BioCryst Pharmaceuticals Inc.'s net income?
BioCryst Pharmaceuticals Inc. (BCRX) reported net income of $264M for fiscal 2025.
Where can I see BCRX's net income history?
The chart and table above show BioCryst Pharmaceuticals Inc.'s net income by year and by quarter, including the growth rate.